MEERA SHAH: Open Payments
NPI 1376152074 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 22 payments from 11 companies in 2025. Trend: 2023 $282 · 2024 $228 · 2025 $858
Food & beverage: $792Education: $66
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $217 |
| Arcutis Biotherapeutics, Inc. | 5 | $181 |
| UCB, Inc. | 1 | $125 |
| Incyte Corporation | 5 | $110 |
| Janssen Biotech, Inc. | 2 | $83 |
| GENZYME CORPORATION | 2 | $36 |
| Lilly USA, LLC | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: VTAMA, Zoryve, Bimzelx, OPZELURA, TREMFYA, DUPIXENT, TALTZ, CIBINQO.
Industry payments across CA — which companies pay providers there.
